Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism BRCA2 inhibitors(BRCA2 DNA repair associated inhibitors), RAD51 inhibitors(DNA repair protein RAD51 homolog 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H24ClN3O3 |
InChIKeyLAVOKBSCOSIGER-UHFFFAOYSA-N |
CAS Registry391889-85-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | IT | 02 Jul 2024 |